Induction of liver-associated transforming growth factor β1 (TGF-β1) mRNA expression by carbon tetrachloride leads to the inhibition of T helper 2 cell-associated lymphokines

Toxicology and Applied Pharmacology

Volumn 144, Issue 1, 1997, Pages 27-35

  Jeon, Young Jin ^a   Han, Seung Hyun ^a   Yang, Kyu Hwan ^a   Kaminski, Norbert E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; LYMPHOKINE; PARACETAMOL; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; IMMUNOSUPPRESSIVE TREATMENT; LIVER INJURY; LIVER TOXICITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; SPLEEN CELL;

ANIMALIA;

EID: 0031149949     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8126     Document Type: Article

References (52)

1. Annoni G., Weiner F. R., Zern M. A. Increased transforming growth factor-β1 gene expression in human liver disease. J. Hepatol. 14:1992;259-264.
2. Armendariz-Borunda J., Seyer J., Kang A., Raghow R. Regulation of TGF-β gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J. 4:1990;215-221.
3. Barral N. M., Barral A., Brownell C. E., Skeiky Y. A., Ellingsworth L. R., Twardzik D. R., Reed S. G. Transforming growth factor-β in leishmanial infection: A parasite escape mechanism. Science. 257:1992;545-548.
4. Berberich I. G., Shu L., Clark E. A. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153:1994;4357-4366.
5. Braun L., Mead J. E., Panzica M., Mikumo R., Bell G. I., Fausto N. Transforming growth factor B mRNA increases during liver regeneration: A possible paracrine mechanism of growth regulation. Proc. Natl. Acad. Sci. USA. 85:1988;1539-1543.
6. Briskin M., Kuwabara M. D., Sigman D. S., Wall R. Induction of kappa transcription by interferon-gamma without activation of NF-κB. Science. 242:1988;1036-1037.
7. Carr B. I., Hayashi I., Barnum E. L., Moses H. L. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type B transforming growth factor. Cancer Res. 46:1986;2330-2334.
8. Chomczynski P., Mackey K. Substitution of chloroform with bromochloroproane in the single-stip method of RNA isolation. Anal. Biochem. 225:1995;163-164.
9. Coffman R., Lebman D., Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 1989;1039-1044.
10. Czaja M., Weiner F., Flanders K., Giambrone M., Wind R., Biempica L., Zern M. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J. Cell. Biol. 108:1989;2477-2482.
11. Delaney B., Strom S. C., Collins S., Kaminski N. E. Carbon tetrachloride suppresses T-cell-dependent immune responses by induction of transforming growth factor-β1. Toxicol. Appl. Pharmacol. 126:1994;98-107.
12. Dunnett C. W. A multiple comparison procedure for sampling severat treatments with a control. J. Am. Stat. Assoc. 50:1955;1096-1121.
13. Fox F. E., Ford H. C., Douglas R., Cherian S., Nowell P. C. Evidence that TGF-β can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms. Cell. Immunol. 150:1993;45-58.
14. Gilliland G., Perrin K., Blanchard K., Bunn H. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 87:1990a;2725-2729.
15. Gilliland G., Perrin S., Bunn H. Competitive PCR for quantitation of mRNA. PCR Protocols: A Guide to Methods and Applications. 1990b;Academic Press, San Diego. p. 60-66.
16. Hines K. L., Kulkarni A. B., McCarthy J. B., Tian H., Ward J. M., Christ M., McCartney-Francis N. L., Furcht L. T., Karlsson S., Wahl S. M. Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc. Natl. Acad. Sci. USA. 91:1994;5187-5191.
17. Houck K. A., Cruise J. L., Michalopoulos G. Norepinephrine modulated the growth-inhibitory effect of transforming growth factor-beta in primary rat hepatocyte cultures. J. Cell. Physiol. 135:1988;551-555.
18. Kaminski N., Barnes D., Jordan S., Holsapple M. The role of metabolism in carbon tetrachloride-mediated immunosuppressionIn vivo. Toxicol. Appl. Pharmacol. 102:1990;9-20.
19. Kaminski N., Jordan S., Holsapple M. P. Suppression of humoral and cell-mediated immune responses by carbon tetrachloride. Fundam. Appl. Toxicol. 12:1989;117-128.
20. Kaminski N. E., Holsapple M. P. Inhibition of macrophage accessory cell function in casein-treated B6C3F1 mice. J. Immunol. 139:1987;1804-1810.
21. Kehrl J., Wakefield L., Roberts A., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M., Fauci A. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1986;1037-1050.
22. Kehrl J. H., Thevenin C., Rieckmann P., Fauci A. S. Transforming growth factor-β suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted from of Ig mRNA. J. Immunol. 146:1991;4016-4023.
23. Lalmanach-Girard A.-C., Chiles T. C., Parker D. C., Rothstein T. L. T cell-dependent induction of NF-κB in B cells. J. Exp. Med. 177:1993;1215-1219.
24. Laskin D. L., Gardner C. R., Price V. F., Jollow D. J. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology. 21:1995;1045-1050.
25. Lebman D., Nomura D., Coffman R., Lee F. Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type beta-induced isotype switching. Proc. Natl. Acad. Sci. USA. 87:1990;3962-3966.
26. Lee H.-M., Rich S. Co-stimulation of T-cell proliferation by transforming growth factor-β1. J. Immunol. 147:1991;1127-1133.
27. Liou H.-C., Sha W. S., Scott M. L., Baltimore D. Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14:1994;5349-5359.
28. Massague J. The transforming growth factor-β family. Annu. Rev. Cell. Biol. 6:1990;597-641.
29. Meade R., Askenase P. W., Geba G. P., Neddermann K., Jacoby R. O., Pasternak R. D. Transforming growth factor-1 inhibits murine immediate and delayed-type hypersensitivity. J. Immunol. 149:1992;521-528.
30. Miller C. L., Feldhaus A. L., Rooney J. W., Rhodes L. D., Sibley C. H., Singh H. Regulation and possible stage-specific function of Oct-2 during pre-B-cell differentiation. Mol. Cell. Biol. 11:1991;4885-4894.
31. Novak T. J., White P. M., Rothenberg E. V. Regulatory anatomy of the murine IL-2 gene. Nucleic Acids Res. 18:1990;4523-4533.
32. Pierce J. W., Lenardo M., Baltimore D. Oligonucleotide that binds nuclear factor NF-κB acts as a lymphoid-specific and inducible enhancer element. Proc. Natl. Acad. Sci. USA. 85:1988;1482-1486.
33. Ruegemer J. J., Ho S. N., Augustine J. A., Schlager J. W., Bell M. P., McKean D. J., Abraham T. R. Regulatory effects of transforming growth factor-β on IL-2- and IL-4-dependent T cell-cycle progression. J. Immunol. 144:1990;1767-1776.
34. Russel W. E. Transforming growth factor beta (TGF-β) inhibits hepatocyte DNA synthesis independently of EGF binding and EGF receptor autophosphorylation. J. Cell. Physiol. 135:1988;253-261.
35. Sad S., Mosmann T. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153:1994;3514-3522.
36. Sen R., Baltimore D. Multible nuclear factors interact with the immunoglobulin enhancer. Cell. 46:1986;703-716.
37. Shull M. M., Ormsby I., Kier A. B., Pawlowski S., Diebold R. J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N., Doetschman T. Targeted disruption of the mouse transforming growth factor-b1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
38. H. J. Immunol. 156:1996;183-191.
39. Sonoda E., Matsumoto R., Hitoshi Y., Ishii T., Sugimoto M., Araki S., Tominaga A., Yamaguchi N., Takatsu K. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 170:1990;1415-1420.
40. Stoeck M., Howe R. C., Mieschler S., von Fliedner V., MacDonald H. R. Effect of transforming growth factor beta on the EL4 thymoma variant EL4/6.1: Dissociation of inhibition of proliferation from expression of IL-1 and IL-2 receptors. Immunobiology. 181:1990;13-21.
41. Stoeck M., Miescher S., MacDonald H. R., Fleidner V. Transforming growth factors beta slow down cell-cycle progression in a murine interleukin 2 dependent T-cell line. J. Cell. Physiol. 141:1989;65-73.
42. Swain S. L., Huston G., Tonkonogy S., Weinberg A. Transforming growth factor-β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 147:1991;2991-3000.
43. Takahama Y., Letterio J. J., Suzuki H., Farr A. G., Singer A. Early progression of thymocytes along the CD4/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing TGF-β J. Exp. Med. 179:1994;1495-1506.
44. Vanden Heuvel J., Clark G., Kohn M., Tritscher A., Greenlee W., Lucier G., Bell D. Dioxin-responsive genes: Examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res. 54:1994;62-68.
45. Vanden Heuvel J., Tyson F., Bell D. Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. BioTechniques. 14:1993;395-398.
46. Voller A. Heterogenous enzyme-immunoassays and their applications. Maggio E. T. Enzyme Immunoassay. 1980;181-186 CRC Press, Boca Raton.
47. Wahl S. M., Hunt D. A., Wong H. L., Dougherty S., McCartney-Francis N., Wahl L. M., Ellingsworth L., Schmidt J. A., Hall G., Roberts A. B., Sporn M. B. Transforming growth factor-β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol. 140:1988;3026-3032.
48. Wakefield L. M., Smith D. M., Masui T., Harris C. C., Sporn M. B. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J. Cell. Biol. 105:1987;965-975.
49. Wirth T., Staudt L., Baltimore D. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature (London). 329:1987;174-178.
50. Xie Q., Chiles T. C., Rothstein T. L. Induction of CREB activity via the surface Ig receptor of B cells. J. Immunol. 151:1993;880-889.
51. Ye J., Ghosh P., Cippitelli M., Subleski J., Hardy K. J., Ortaldo J. R., Young H. A. Characterization of a bifunctional regulatory element in human IFN-γ promoter. J. Biol. Chem. 269:1994;25728-25734.
52. Young H. A., Hardy K. J. Role of interferon-g in immune cell regulation. J. Leukocyte Biol. 58:1995;373-381.